Asghariazar Vahid, Kadkhodayi Mahtab, Sarailoo Mehdi, Jolfayi Amir Ghaffari, Baradaran Behzad
Cancer Immunology and Immunotherapy Research Center, Ardabil University of Medical Sciences, Ardabil, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Deputy of Research and Technology, Ardabil University of Medical Sciences, Ardabil, Iran.
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Animal Biology, Faculty of Natural Sciences, The University of Tabriz, Tabriz, Iran.
Pathol Res Pract. 2023 Oct;250:154792. doi: 10.1016/j.prp.2023.154792. Epub 2023 Sep 6.
MicroRNAs (MiRNAs), which are highly conserved and small noncoding RNAs, negatively regulate gene expression and influence signaling pathways involved in essential biological activities, including cell proliferation, differentiation, apoptosis, and cell invasion. MiRNAs have received much attention in the past decade due to their significant roles in cancer development. In particular, microRNA-143 (miR-143) is recognized as a tumor suppressor and is downregulated in most cancers. However, it seems that miR-143 is upregulated in rare cases, such as prostate cancer stem cells, and acts as an oncogene. The present review will outline the current studies illustrating the impact of miR-143 expression levels on cancer progression and discuss its target genes and their relevant signaling pathways to discover a potential therapeutic way for cancer.
微小RNA(miRNA)是高度保守的小非编码RNA,它通过负向调节基因表达来影响参与细胞增殖、分化、凋亡和细胞侵袭等基本生物学活动的信号通路。由于miRNA在癌症发展中具有重要作用,在过去十年中受到了广泛关注。特别是,微小RNA-143(miR-143)被认为是一种肿瘤抑制因子,在大多数癌症中表达下调。然而,在少数情况下,如前列腺癌干细胞中,miR-143似乎会上调,并发挥癌基因的作用。本综述将概述目前有关miR-143表达水平对癌症进展影响的研究,并讨论其靶基因及其相关信号通路,以探寻潜在的癌症治疗方法。